BRNS Stock Analysis: Buy, Sell, or Hold?
BRNS - Barinthus Biotherapeutics plc American Depositary Shares
$0.73
0.01 (1.19%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When BRNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BRNS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: BRNS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: BRNS is currently trading at $0.73, which is considered fair relative to its 30-day fair value range of $0.70 to $0.75.
Technical Outlook: Technically, BRNS is in a strong downtrend. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BRNS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.50 (+653.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BRNS is in a strong downtrend. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BRNS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.50 (+653.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.70 -
$0.75
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 653.4% below Wall St target ($5.50)
Fair Price Analysis
30-Day Fair Range
$0.70 -
$0.75
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$0.75
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.55
Wall Street Target
$5.50
(+653.4%)
Revenue Growth (YoY)
-100.0%
Last updated: February 01, 2026 5:52 PM ET
Data refreshes hourly during market hours. Next update: 6:52 PM
Data refreshes hourly during market hours. Next update: 6:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 60 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 59 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 54 HOLD |
